Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| KLS-6188-08-2024 | Other Grant/Funding Number | Ligue suisse contre le cancer |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Heidelberg University | OTHER |
Not provided
Not provided
Not provided
Not provided
Communication in the oncology setting involves cognitive as well as emotional challenges for both clinicians and patients, and interactional dimensions that emerge in their encounter. Supervision of oncology/haematology clinicians by psycho-oncologists is one of the most frequently used tools, which aims to enhance their communicative and relational competences, and at the same time to support them in their daily clinical work. However, little is known regarding its impact and how the supervisory process acts upon clinicians. This study thus aims to evaluate the efficacy of four 1-hour supervision sessions following a clinician-centred format, which allows supervisors to rapidly access supervisees' own difficulties in the encounter with certain patients. In addition, the supervisory process will be examined qualitatively by analysing in-depth audio-taped supervision sessions. The focus of analysis will be "what works" and "what does not". If beneficial effects are found, clinician-centred supervision -- thanks to its focused and time saving format -- could be realistically implemented for nurses and physicians working in the oncology and haematology settings. Effects are expected on clinicians' capacity to reflect on challenging encounters with patients, on potential negative feelings towards patients, and on clinicians' professional well-being. The clinician-centred supervision format could be easily taught to psycho-oncologists who wish to start supervising haematology and oncology clinicians. Clinicians who are less preoccupied with themselves, or with negative feelings towards their patients, have more supportive relationships with them, which is of utmost importance in critical settings such as oncology and haematology.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Supervision group (SPV) | Experimental | As baseline assessments (T0), participants will complete the Maslach Burnout Inventory (MBI) and 5-day clinical situation recordings (measuring supervisee's reflexivity) in which they describe a clinical situation that has remained in their mind during the day. Each participant will then take part in four 60 min clinician-centred supervision sessions (bi-monthly supervisions). During each supervision, (i) clinicians' feelings toward the patients presented will be measured with the Feeling Word Checklist (FWC-58) at the beginning and end of each session, and (ii) specific aspect and the overall quality of the supervision wil be assessed with a 4-item ad-hoc questionnaire for both supervisee and the supervisor. Assessments performed at T0 will be repeated after the 2-month intervention (T1). Finally, the MBI will be administered at follow-up assessments 3 months (FU3) and 6 months (FU6) after T1. |
|
| Waiting-control group (CTRL) | No Intervention | As baseline assessments (T0), participants will complete the Maslach Burnout Inventory (MBI) and 5-day clinical situation recordings (measuring supervisee's reflexivity). The clinical situation recordings consist of describing a clinical situation that has remained in the clinician's mind during the day. They will then not receive supervisions during the 2-month waiting period. Assessments will be repeated after the 2-month waiting period (T1: MBI and 5-day clinical situation recordings) and follow-up evaluations with the MBI will take place at 3 months (FU3) and 6 months (FU6). After the trial period (i.e., after FU6), participants in this arm will be offered the opportunity to reveice the intervention. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Supervision session | Other | In the first and thrid sessions, supervisees will comprehensively describe a clinical situation with a patient, which strongly affected them in a very negative way (e.g., feelings of rejection, anxiety, anger), or even lead to words (e.g., outbursts, impoliteness, cynicism) and actions (e.g., avoidance of the patient, forgetting appointments, deviation from good medical practice). In the second and fourth sessions, the same proceeding takes place, with the exception that participants are invited to present a clinical encounter with a patient, which strongly affected them in a very positive way (e.g., feelings of intense closeness, sympathy, pronounced mourning after the patient's death), or even lead to words (e.g., self-disclosure, discussing private information, compliments) and actions (e.g., special favours, difficulties to end treatment, deviation from good medical practice). |
| Measure | Description | Time Frame |
|---|---|---|
| Supervisee's reflexivity (qualitative classification) | Reflexivity will be assessed with the reflexivity indicator, a 4-level framework for classifying clinicians' narratives identified in the 5-day clinical situation recordings. This indicator has been developped in a previous study (in preparation) with the following level:
| Baseline (T0) and 2 months post-baseline (i.e., T1: after the 2 months of supervision for the SPV group or 2 months waiting period for the CTRL group) |
| Measure | Description | Time Frame |
|---|---|---|
| Feeling towards patients (questionnaire) | For the SPV group only, clinicians' feelings towards presented patients will be measured with the Feeling Word Checklist (FWC; 58 items), a self-report questionnaire, prior and immediately after each supervison session. Clinicians are invited to indicate if and to what extent (5 point rating scale with 0 = not at all, and 4 = very much) the feeling described through the words are experienced regarding a given patient. We will use a translated version (french version) of the FWC. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Psychiatrie de liaison | Lausanne | Canton of Vaud | 1011 | Switzerland |
There is not a plan to make IPD available
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
| D000077062 | Burnout, Psychological |
| ID | Term |
|---|---|
| D013315 | Stress, Psychological |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
Not provided
Not provided
Participants will be randomized in an intervention (Supervision group: SPV) group with supervision sessions and a waiting-control (CTRL) group.
Not provided
Not provided
Not provided
|
| From supervision 1 to 4 during the 2-month intervention period (only for SPV group) |
| Burnout (questionnaire) | The Maslach Burnout Inventory (MBI) will measure the burnout level using its 22 items divided into three scales: emotional exhaustion, depersonalization, and personal accomplishment, rated on a 6-point scale (with 0 = never, and 6 = every day). Scores for each scale are obtained by summing the responses of the corresponding items. | Baseline (T0), 2 months post-baseline (T1), 3 months follow-up (FU3) and 6 months follow-up (FU6) |
| Supervision assessment (questionnaire) | For the SPV group only, specific aspects and the overall quality of each supervision session will be assessed using a 4-item ad-hoc questionnaire completed by both the supervisee and the supervisor. The first part evaluates specific aspects of the supervision (3 items) on a 5-point Likert scale ranging from "not true at all" to "absolutely true", while the second part assesses the overall quality of the session on a 5-point scale from "unsatisfactory" to "exceptionally satisfactory". A global score, calculated by summing all responses, reflects overall satisfaction with the supervision. . | From supervision 1 to 4 during the 2-month intervention period (only for SPV group) |